Mitris Resilia Mitral Valve
Payments companies reported to CMS as associated with Mitris Resilia Mitral Valve. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mitris Resilia Mitral Valve, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mitris Resilia Mitral Valve
These are the largest totals companies reported as associated with Mitris Resilia Mitral Valve. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Farivar | Boise, ID | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $20,169.81 |
| Brian Bethea | Delray Beach, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $16,533.25 |
| Kevin Accola | Orlando, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $12,800.65 |
| Tom Nguyen | Miami, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $11,499.08 |
| Matthew Romano | Ann Arbor, MI | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $9,901.20 |
| Leonard Lee | Hackensack, NJ | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $6,985.73 |
| Jacob Delarosa | Pocatello, ID | Cardiovascular Disease | $6,360.59 |
| Jonathan Hoffberger | Sarasota, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $6,221.04 |
| Sebastian Pagni | Louisville, KY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $5,695.75 |
| Pavan Atluri | Philadelphia, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $5,240.95 |
Prescribed Mitris Resilia Mitral Valve?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.